InvestorsHub Logo
Followers 42
Posts 4132
Boards Moderated 0
Alias Born 01/04/2017

Re: None

Saturday, 01/01/2022 8:02:24 AM

Saturday, January 01, 2022 8:02:24 AM

Post# of 118384
New article out on RGBP!!!

There are also plenty of buyout rumors on RGBP; according to many investors It appears there may be a possible merger acquisition looming with Precigen or another big pharma which would make sense as the CEO of Precigen (PGEN) Helen Sabzevari is on RGBP’s Scientific Advisory Board. PGEN trades on Nasdaq with a Market Cap of $766 million. RGBP is in the same clinical therapeutic niche market of Oncology-Immunology candidate drug development that Precigen is in including the same mRNA vaccine technology so logically speaking it would make sense if PGEN straight up buys-out RGBP or does a merger acquisition and the motive to do this are the numerous valuable Patents RGBP owns that address enormous billion-dollar markets.

https://microcapdaily.com/regen-biopharma-inc-otcmkts-rgbp-northbound-as-biotech-grows-valuable-patent-portfolio-grants-2-licenses-to-oncology-pharma-for-1-9-million/
--------------------------

If this doesn't make RGBP skyrocket, I'm not sure what will...!!!